BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
GATA1
,
Fatty acid metabolic process
,
Breast Cancer
,
Heart
,
Biofuel
,
Aspirin
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PDE-1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Globus pallidus
Heart
Heart ventricle
Corpus callosum
Nodose nucleus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Atherosclerotic occlusive disease
Myocardial ischemia
Disease due to Togaviridae
Hypertrophic cardiomyopathy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carticaine
Sulfachlorpyridazine
Botulinum Toxins
flumequine
hydrocotarnine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CanA1
PINK1
AFF4
PDE1C
TIA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Cyclic nucleotide phosphodiesterase 1C contributes to abdominal aortic aneurysm.
Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic card…
Role of cAMP-phosphodiesterase 1C signaling in regulating growth factor receptor stability, vascular…
A dominant variant in the PDE1C gene is associated with nonsyndromic hearing loss.
PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of PDE MAX
Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients
Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes
Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ